Silo Pharma acquires QwikAgents software and domains for 2.1M shares

Silo Pharma, Inc.

Asset purchase agreement with Many Ads Inc. for QwikAgents web application and domain names (qwikagents.com, .ai, .co).
Consideration: 2,100,000 unregistered shares of Silo Pharma common stock, issued under Section 4(a)(2) exemption.
Agreement includes customary representations, warranties, and indemnification provisions; liability capped at Purchase Price.
Software includes Next.js/React portal and MCP server; open-source components disclosed (LGPL dependency noted).
Transaction closed on March 30, 2026; domain transfer pending registrar processing.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Silo Pharma, Inc. entered into Agreement with Many Ads Inc. (effective 2025-07-29).

Action: entry
Agreement: asset purchase
Counterparty: Many Ads Inc.
Effective: 2025-07-29

Exact text from the filing

On July 29, 2025, Silo Pharma, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) with Many Ads Inc. (the “Seller”).

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Silo Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-039352

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.